IS3987A - Efnablöndur sem innihalda N-(fosfónóasetýl)-L-asparsýru og aðferðir við notkun þeirra sem breiðvirkefni gegn veirum - Google Patents

Efnablöndur sem innihalda N-(fosfónóasetýl)-L-asparsýru og aðferðir við notkun þeirra sem breiðvirkefni gegn veirum

Info

Publication number
IS3987A
IS3987A IS3987A IS3987A IS3987A IS 3987 A IS3987 A IS 3987A IS 3987 A IS3987 A IS 3987A IS 3987 A IS3987 A IS 3987A IS 3987 A IS3987 A IS 3987A
Authority
IS
Iceland
Prior art keywords
phosphonoacetyl
methods
aspartic acid
antiviral agent
preparations containing
Prior art date
Application number
IS3987A
Other languages
English (en)
Inventor
A. Blough Herbert
Original Assignee
U.S. Bioscience, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/032,234 external-priority patent/US5491135A/en
Application filed by U.S. Bioscience, Inc. filed Critical U.S. Bioscience, Inc.
Publication of IS3987A publication Critical patent/IS3987A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS3987A 1992-03-18 1993-03-18 Efnablöndur sem innihalda N-(fosfónóasetýl)-L-asparsýru og aðferðir við notkun þeirra sem breiðvirkefni gegn veirum IS3987A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85345492A 1992-03-18 1992-03-18
US08/032,234 US5491135A (en) 1992-03-18 1993-03-17 Compositions of N-(phosphonoacetyl)-L-aspartic acid and methods of their use as broad spectrum antivirals

Publications (1)

Publication Number Publication Date
IS3987A true IS3987A (is) 1993-09-19

Family

ID=26708159

Family Applications (1)

Application Number Title Priority Date Filing Date
IS3987A IS3987A (is) 1992-03-18 1993-03-18 Efnablöndur sem innihalda N-(fosfónóasetýl)-L-asparsýru og aðferðir við notkun þeirra sem breiðvirkefni gegn veirum

Country Status (10)

Country Link
EP (1) EP0660710A1 (is)
JP (1) JPH07507770A (is)
CN (1) CN1080853A (is)
AU (1) AU3965993A (is)
BR (1) BR9306123A (is)
CA (1) CA2109435C (is)
IL (1) IL105090A (is)
IS (1) IS3987A (is)
MX (1) MX9301527A (is)
WO (1) WO1993018763A1 (is)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US20030100532A1 (en) 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
AU753336B2 (en) 1997-11-10 2002-10-17 G.D. Searle & Co. Use of alkylated iminosugars to treat multidrug resistance
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
JP2002502875A (ja) 1998-02-12 2002-01-29 ジー・ディー・サール・アンド・カンパニー 肝炎ウイルス感染症を処置するためのｎ−置換−１，５−ジデオキシ−１，５−イミノ−ｄ−グルシトール化合物の使用
ATE402701T1 (de) 1999-02-12 2008-08-15 United Therapeutics Corp N-(8,8,8-trifluorooctyl)-1,5-dideoxy-1,5-imino- - glucitol zur behandlung von hepatitis-virus- infektionen
JP2003505501A (ja) 1999-02-12 2003-02-12 ジー・ディー・サール・アンド・カンパニー 肝炎ウィルス感染の処置のためのグルカミン化合物
WO2001045727A2 (en) * 1999-12-20 2001-06-28 New Pharma Research Sweden Ab Stabilized veterinary compositions comprising more than one antiviral agent
DE10138912A1 (de) * 2001-08-08 2003-02-27 Medinnova Ges Med Innovationen Verwendung von Wirksubstanzen zur Prophylaxe und/oder Therapie von Viruserkrankungen sowie Testsystem zum Auffinden solcher Wirksubstanzen
DE10343365A1 (de) * 2003-09-17 2005-04-14 Biosphings Ag Pharmazeutische Formulierungen von Xanthogenaten und Hemmstoffen der viralen Nukleinsäurereplikation
US8236768B2 (en) 2008-10-03 2012-08-07 3B Pharmaceuticals, Inc. Topical antiviral formulations
WO2021189444A1 (zh) * 2020-03-24 2021-09-30 中国人民解放军海军军医大学 利福霉素类抗生素在制备抗黄热病毒感染药物中的应用
CN111317733B (zh) * 2020-03-24 2022-07-12 中国人民解放军海军军医大学 利福霉素类抗生素在制备抗黄热病毒感染药物中的应用
CN111419839A (zh) * 2020-03-31 2020-07-17 远见生物科技（上海）有限公司 利福霉素的新用途
EP4162952A1 (en) * 2020-04-30 2023-04-12 Kyoto University Prophylactic or therapeutic agent for rna virus-related diseases
WO2022200615A1 (en) * 2021-03-26 2022-09-29 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Pyrimidine biosynthesis inhibitor combination for use in treating viral infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4178306A (en) * 1978-08-10 1979-12-11 Parsons Jack L Preparation of N-(phosphonoacetyl)-L-aspartic acid

Also Published As

Publication number Publication date
MX9301527A (es) 1994-02-28
AU3965993A (en) 1993-10-21
WO1993018763A1 (en) 1993-09-30
JPH07507770A (ja) 1995-08-31
IL105090A (en) 1998-08-16
EP0660710A1 (en) 1995-07-05
EP0660710A4 (en) 1995-03-02
CA2109435A1 (en) 1993-09-19
BR9306123A (pt) 1997-08-26
IL105090A0 (en) 1994-08-26
CA2109435C (en) 1997-03-11
CN1080853A (zh) 1994-01-19

Similar Documents

Publication Publication Date Title
IS3987A (is) Efnablöndur sem innihalda N-(fosfónóasetýl)-L-asparsýru og aðferðir við notkun þeirra sem breiðvirkefni gegn veirum
EP0201852A3 (en) Agent against noxious plants based on pyrazol derivatives
GB1548553A (en) Addition compound of dipeptide derivative and amino acid derivative
IL95372A0 (en) Amino acid amides and pharmaceutical compositions containing them
DE122005000012I2 (de) N-(Pyrrolo(2-3-d)pyrimidin-3-ylacyl-Glutamins{urederivate
HUT41765A (en) Herbicide composition containing 5-amino-1-pyridyl-pyrazole derivatives and process for producing the active agents
ZA892922B (en) Biphenylacetic acid gel(3%)
ZA931934B (en) Compostitions of N-(phosphonoacetyl)-L-aspartic acid and methods of their use as broad spectrum antivirals
NO930760L (no) Substituerte fenyleddiksyreamider
DE3279468D1 (en) Peptide synthesis and amino acid blocking agents
GB8524879D0 (en) N-substituted amino acid derivatives
PH15717A (en) N-(1-(3-benzoylpropyl)-4-piperidyl)-sulfonic acid amides and salts thereof
NO930722L (no) Imidazolylsubstituerte fenyleddiksyreamider
DE59107135D1 (de) Phoshponsäure- und Thionophosphonsäure-Derivate
DK156484D0 (da) Aminosyrederivater
DK489384D0 (da) 6alfa-(1-hydroxyethyl)-2-(dioxacycloalkyl)alkylthio-2-penem-3-carboxylsyre-forbindelser og farmaceutisk praeparat
DK489584D0 (da) 6alfa-(1-hydroxyethyl)-2-azacycloalkylthio-2-penem-3-carboxylsyre-forbindelser og farmaceutisk praeparat
IL72602A (en) 2(5-isopropyl-5-methyl-4-oxo-1-imidazolin-2-yl)benzoic acid analogs and use thereof as herbicidal agents
HUT41961A (en) Herbicide compositions containing thienyl-sulfonyl-guanidine derivatives as active agents and process for producing the active agents
HUT42463A (en) Herbicide compositions containing thiazolyl-amide derivatives as active agents and process for producing thiazolyl-amide derivatives
JPS5481205A (en) Amine and amino acid derivatives
DK344384D0 (da) 2-heterocyclylalkylthio-6-(alfa-hydroxyethyl)-2-penem-3-carboxylsyre-forbindelser og farmaceutiske praeparater indeholdende disse
ZA847975B (en) Beta-elemonic acid and pharmaceutical preparations
KR900007857A (ko) 1,4,2-옥사자포스폴리딘-4-아세트산, 2-알콕시-2-옥사이드의 아민염
DK33284D0 (da) Pyrrol-2-acetylaminosyre-derivater